Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
21467 | 360 | 41.4 | 90% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1187 | 8873 | RESTENOSIS//INTRAVASCULAR BRACHYTHERAPY//TRANILAST |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TRANSCRIPTION FACTOR DECOY | Author keyword | 17 | 57% | 6% | 20 |
2 | DECOY | Author keyword | 11 | 26% | 10% | 36 |
3 | DECOY OLIGODEOXYNUCLEOTIDE | Author keyword | 6 | 47% | 3% | 9 |
4 | PNA DNA CHIMERAS | Author keyword | 5 | 60% | 2% | 6 |
5 | CIS ELEMENT DECOY | Author keyword | 3 | 50% | 1% | 5 |
6 | CLIN GENE THER Y MED | Address | 3 | 100% | 1% | 3 |
7 | OLIGONUCLEOTIDE DECOY | Author keyword | 3 | 100% | 1% | 3 |
8 | NF KAPPA B DECOY | Author keyword | 3 | 37% | 2% | 7 |
9 | DECOY STRATEGY | Author keyword | 3 | 60% | 1% | 3 |
10 | THER IE CELLULAIRE MOL | Address | 2 | 67% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TRANSCRIPTION FACTOR DECOY | 17 | 57% | 6% | 20 | Search TRANSCRIPTION+FACTOR+DECOY | Search TRANSCRIPTION+FACTOR+DECOY |
2 | DECOY | 11 | 26% | 10% | 36 | Search DECOY | Search DECOY |
3 | DECOY OLIGODEOXYNUCLEOTIDE | 6 | 47% | 3% | 9 | Search DECOY+OLIGODEOXYNUCLEOTIDE | Search DECOY+OLIGODEOXYNUCLEOTIDE |
4 | PNA DNA CHIMERAS | 5 | 60% | 2% | 6 | Search PNA+DNA+CHIMERAS | Search PNA+DNA+CHIMERAS |
5 | CIS ELEMENT DECOY | 3 | 50% | 1% | 5 | Search CIS+ELEMENT+DECOY | Search CIS+ELEMENT+DECOY |
6 | OLIGONUCLEOTIDE DECOY | 3 | 100% | 1% | 3 | Search OLIGONUCLEOTIDE+DECOY | Search OLIGONUCLEOTIDE+DECOY |
7 | NF KAPPA B DECOY | 3 | 37% | 2% | 7 | Search NF+KAPPA+B+DECOY | Search NF+KAPPA+B+DECOY |
8 | DECOY STRATEGY | 3 | 60% | 1% | 3 | Search DECOY+STRATEGY | Search DECOY+STRATEGY |
9 | TRANSCRIPTION FACTOR DECOY TFD | 2 | 67% | 1% | 2 | Search TRANSCRIPTION+FACTOR+DECOY+TFD | Search TRANSCRIPTION+FACTOR+DECOY+TFD |
10 | DECOY OLIGONUCLEOTIDES | 2 | 50% | 1% | 3 | Search DECOY+OLIGONUCLEOTIDES | Search DECOY+OLIGONUCLEOTIDES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TRANSCRIPTION FACTOR DECOY | 31 | 39% | 17% | 62 |
2 | CIS ELEMENT DECOY | 20 | 41% | 11% | 38 |
3 | HUMAN PRIMARY OSTEOCLASTS | 13 | 80% | 2% | 8 |
4 | IN VIVO TRANSFECTION | 7 | 20% | 9% | 32 |
5 | DECOY OLIGODEOXYNUCLEOTIDE | 6 | 100% | 1% | 4 |
6 | GENERATED DNA FRAGMENTS | 4 | 75% | 1% | 3 |
7 | PNA DNA CHIMERAS | 4 | 50% | 2% | 6 |
8 | E2F DECOY OLIGODEOXYNUCLEOTIDES | 3 | 60% | 1% | 3 |
9 | E2F DECOY | 2 | 24% | 2% | 8 |
10 | ACIDS PNA DNA CHIMERAS | 2 | 67% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Modification of Decoy Oligodeoxynucleotides to Achieve the Stability and Therapeutic Efficacy | 2012 | 6 | 28 | 46% |
Molecular therapy to inhibit NF kappa B activation by transcription factor decoy oligonucleotides | 2004 | 66 | 40 | 50% |
Decoy oligodeoxyribonucleotides and peptide nucleic acids-DNA chimeras targeting nuclear factor kappa-B: Inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa | 2010 | 12 | 79 | 41% |
Development and Modification of Decoy Oligodeoxynucleotides for Clinical Application | 2012 | 1 | 25 | 60% |
Targeting Transcription Factor Activity as a Strategy to Inhibit Pro-Inflammatory Genes Involved in Cystic Fibrosis: Decoy Oligonucleotides and Low-Molecular Weight Compounds | 2010 | 17 | 83 | 25% |
Regulation of NF-kappa B signaling by decoy oligodeoxynucleotides | 2006 | 32 | 27 | 30% |
NF kappa B decoy oligonucleotides | 2010 | 12 | 134 | 25% |
Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease | 1998 | 124 | 51 | 20% |
Therapeutic Effect of Ribbon-Type Nuclear Factor-kappa B Decoy Oligonucleotides in a Rat Model of Inflammatory Bowel Disease | 2012 | 2 | 38 | 29% |
Regulation of activity of transcription factor NF-kappa B by synthetic oligonucleotides | 2013 | 1 | 73 | 33% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLIN GENE THER Y MED | 3 | 100% | 0.8% | 3 |
2 | THER IE CELLULAIRE MOL | 2 | 67% | 0.6% | 2 |
3 | ER GENTECH | 2 | 17% | 2.5% | 9 |
4 | KOREAN MINIST SCI TECHNOL | 1 | 38% | 0.8% | 3 |
5 | CELLULAR BIOCHEM SECT | 1 | 12% | 1.9% | 7 |
6 | DNA THER EUT | 1 | 50% | 0.3% | 1 |
7 | MODEL ORGANISMS | 1 | 50% | 0.3% | 1 |
8 | OSAKA UNIVKANAZAWA UNIV | 1 | 50% | 0.3% | 1 |
9 | PRO SANGUE HEMO | 1 | 50% | 0.3% | 1 |
10 | TRADIT MICROORGAN OURCES TMR | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000204275 | HEMAGGLUTINATING VIRUS OF JAPAN//GAX//HVJ LIPOSOME |
2 | 0.0000109314 | PHOSPHOROTHIOLATE//P 32ORTHOPHOSPHORIC ACID//SYNTHESIS OF P 32 LABELED NUCLEOTIDES |
3 | 0.0000092133 | I KAPPA B//IKK//C REL |
4 | 0.0000088934 | RAT AORTIC SMOOTH MUSCLE CELL//CINNAMOMUM CASSIA BARK//CLITOCYBIN A |
5 | 0.0000086714 | PEPTIDE NUCLEIC ACIDS//PEPTIDE NUCLEIC ACID//PNA |
6 | 0.0000078234 | CALPAIN 9//CT26 COLORECTAL ADENOCARCINOMA//DELTA PSIM |
7 | 0.0000077384 | ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT//ANTISENSE RESEARCH AND DEVELOPMENT//ANTISENSE |
8 | 0.0000067024 | THY 1 NEPHRITIS//GLOMERULAR BIOENGN UNIT//MESANGIAL CELL |
9 | 0.0000061080 | VEIN GRAFT//VEIN GRAFTS//INTIMAL HYPERPLASIA |
10 | 0.0000057156 | HMC05//HEBEI PROV PEOPLES HOSP//DIPARTIMENTO CHIRURG GEN PARIDE STEFANINI |